Clinical trial

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

NCT04829019

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-04-07

PhasePHASE2

Study timeline

Study start (estimated)2021-04-07Date precision: day

Registry last updated2021-04-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neurocognitiveunresolved

Interventions

Osimertinib and whole-brain irradiationRADIATION

OsimertinibDRUG · verified · RxNorm: osimertinib

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04829019 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.